Status: Recruiting
T2 Star Magnetic Resonance Imaging and Biomarker Blood Testing to Predict the Change and Progress of Malignant Gliomas
This clinical trial studies whether T2 star (T2\*) magnetic resonance imaging (MRI) and biomarker blood testing can help predict how World Health Organization (WHO) grade IV gliomas (malignant gliomas) might change or progress over time.
Participants needed: 15
Trial details
Age: 21+Biological sex: AllType: InterventionalSponsor: John M. BuattiUpdated: Mar 3, 2026Locations: 1
Eligibility criteria
Age > 21 years [+3]
History of previous malignancy other than non-melanoma skin cancer in the previo... [+2]